ArticleGlobal health, science and practice2026
Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study.
Article in Global health, science and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study.Global health, science and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionInnovative private pharmacy distribution channels, including delivery services, telepharmacy, and e-pharmacies, have emerged as potential solutions to improve access to quality-assured medicine and pharmacy services in Zambia, but limited evidence exists regarding their impact on medicine quality and safety. This qualitative study provides the first comprehensive investigation of stakeholder perspectives on these channels, examining their implications for pharmaceutical quality assurance and distribution in Zambia's health care system.
methodsA purposive sample of 15 stakeholders participated in the study, selected to represent key sectors of the pharmaceutical supply chain, including wholesalers, innovators, retailers, national medicine supply agencies, national medicine regulators, professional pharmacy bodies, and supply chain experts. Semi-structured interviews were conducted until data saturation was achieved. Interviews were recorded and transcribed, and a bottom-up thematic analysis was employed to derive themes directly from the data.
resultsThemes that emerged from the analysis fell into 4 interconnected categories of issues: (1) current challenges in the pharmaceutical supply chain (including affordability barriers, transportation limitations, and regulatory constraints) affecting both traditional and innovative pharmacy services, (2) potential benefits of the innovative pharmacy approaches (such as enhanced traceability and improved quality assurance), (3) limitations and shortcomings (including technical and behavioral challenges), and (4) recommendations for improvement. Stakeholder perspectives varied notably by role, with regulators emphasizing quality control and innovators focusing on accessibility and efficiency.
conclusionThe findings suggest that innovative pharmacy distribution approaches will be constrained by some of the same regulatory and structural issues faced by traditional pharmacy systems, and thus cannot fully circumvent existing challenges of access to quality pharmacy services and medicines in Zambia and other countries. To successfully realize the potential of pharmacy innovations to improve accessibility to good-quality medicines, balanced attention is required to technological advancement, regulatory compliance, and the local context. These insights offer actionable guidance for policymakers and stakeholders seeking to strengthen medicine distribution systems, enriching the broader narrative of health care delivery in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.